Posts Tagged ‘Securities Law’
Brady Berman
副律师 简介 Bonnie Bai 是 Sichenzia Ross Ference Carmel (SRFC) 的法律助理，也是该公司企业、并购和证券业务团队的成员。她于 2022 年通过了纽约律师考试，正在等待录取。 Bonnie于2019年取得中国国家律师资格。 在加入 SRFC 之前，Bonnie 曾在一家总部位于纽约的国际投资公司工作，负责处理与私募基金、RIA 和经纪自营商相关的合规问题。来美国之前，她曾在北京一家知名律师事务所担任律师，处理多个企业法律问题。此外，她在中国还获得了诉讼、仲裁和交易经验。 教育 白女士于2022年以优异的成绩获得西北普利兹克法学院美国法法学硕士学位。她在北京第二外国语大学获得法学学士学位。 律师资格 她于 2022 年通过了纽约律师考试，正在等待录取。 Bonnie于2019年取得中国国家律师资格。 语言 Bonnie的母语是普通话，她能说流利的英语。 执业领域 资本市场 联系地址 办公室：纽约 电话： (212) 930-9700 直拨: (939) 232-1880 传真： (212) 930-9725 电子邮件: bbai@srfc.law Download vCard not assigned Corporate Law | pa capital markets | Securities Law
Read MoreSichenzia Ross Ference Carmel LLP represents The Benchmark Company, LLC in $5.2 Million Initial Public Offering of Gelteq Limited
Sichenzia Ross Ference Carmel LLP Represents BioSig Technologies, Inc. in $3 Million Registered Direct Offering
Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $5 Million Registered Direct Offering
Press Release – New York, NY – May 17, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, in a $5 million registered direct offering. The Company sold an aggregate of 2,402,935 common…
Read MoreSichenzia Ross Ference Carmel LLP Represents Siyata Mobile in a $4 Million Public Offering
Sichenzia Ross Ference Carmel LLP Represents INmune Bio Inc. in $9.7 Million Registered Direct Offering
Sichenzia Ross Ference Carmel LLP Represents Alternus Clean Energy, Inc. in a $2.16 Million Private Placement
Sichenzia Ross Ference Carmel LLP Represents Genetic Technologies Limited in a $2 Million Registered Direct Offering and Concurrent Private Placement
Sichenzia Ross Ference Carmel LLP Represents Craft Capital Management LLC and R.F. Lafferty & Co. in a $4.2 Million Initial Public Offering and Nasdaq Listing of Mingteng International Corporation
Sichenzia Ross Ference Carmel LLP Represents EF Hutton LLC in a $2 Million Common Stock Offering of NRx Pharmaceuticals, Inc.
